BiomX (PHGE) Institutional Ownership $0.52 -0.21 (-28.96%) Closing price 05/22/2025 03:59 PM EasternExtended Trading$0.53 +0.01 (+0.95%) As of 05/22/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsBuy This Stock Institutional Ownership Changes (13F Filings) for BiomX (NYSEMKT:PHGE)CurrentInstitutional OwnershipPercentage40.57%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$3.79MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$3.50M Get PHGE Insider Trade Alerts Want to know when executives and insiders are buying or selling BiomX stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHGE Institutional Buying and Selling by Quarter BiomX Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Allostery Investments LP940,629$523K0.8%+46.1%3.763% 5/16/2025 Alyeska Investment Group L.P.1,590,738$884K0.0%+83.8%6.364% 5/16/2025 ADAR1 Capital Management LLC299,598$166K0.0%N/A1.199% 5/15/2025 Nantahala Capital Management LLC2,493,309$1.39M0.1%+44.1%9.975% 5/9/2025 Warberg Asset Management LLC99,616$55K0.0%N/A0.399% 5/6/2025 AIGH Capital Management LLC1,566,944$871K0.4%+81.1%6.269% 2/17/2025 Alyeska Investment Group L.P.865,400$632K0.0%N/A4.761% 2/17/2025 Allostery Investments LP643,833$470K0.5%N/A3.542% 2/14/2025 Heights Capital Management Inc.258,492$189K0.1%-56.1%1.422% 2/14/2025 Johnson & Johnson96,866$71K0.0%-49.6%0.533% Get the Latest News and Ratings for PHGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025 JPMorgan Chase & Co.429,990$314K0.0%N/A2.366% 11/19/2024 Barclays PLC25,000$26K0.0%-90.0%0.138% 11/15/2024 Barclays PLC25,000$26K0.0%-90.0%0.140% 11/15/2024 Ikarian Capital LLC893,000$911K0.1%N/A4.990% 11/14/2024 Johnson & Johnson192,321$196K0.0%-90.0%1.075% 11/7/2024 8VC GP I LLC108,621$111K0.2%-90.0%0.607% 5/17/2024 Ikarian Capital LLC10,817,327$4.87M0.5%N/A19.590% 5/10/2024 Johnson & Johnson1,923,201$865K0.0%-9.9%3.483% 11/3/2022 Royce & Associates LP158,655$54K0.0%-51.7%0.529% 5/5/2022 Royce & Associates LP320,655$619K0.0%+200.5%1.077% 2/7/2022 Royce & Associates LP106,696$171K0.0%-52.7%0.373% 11/12/2021 Johnson & Johnson2,133,402$6.53M0.6%N/A7.568% 10/26/2021Taylor Wealth Management Partners40,098$91K0.0%-44.3%0.142% 8/17/2021 Millennium Management LLC427,702$2.34M0.0%-5.9%1.758% 8/17/2021 Bridgeway Capital Management LLC104,000$568K0.0%-15.4%0.427% 5/18/2021 Millennium Management LLC454,377$3.24M0.0%-1.2%1.954% 5/18/2021 Jane Street Group LLC25,365$181K0.0%N/A0.109% 5/13/2021 Renaissance Technologies LLC36,200$258K0.0%N/A0.156% 5/10/2021 Royce & Associates LP359,000$2.56M0.0%N/A1.544% (Data available from 1/1/2016 forward) PHGE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHGE shares? During the previous two years, 12 institutional investors and hedge funds held shares of BiomX. The most heavily invested institutionals were Nantahala Capital Management LLC ($1.39M), Ikarian Capital LLC ($911K), Alyeska Investment Group L.P. ($884K), AIGH Capital Management LLC ($871K), Allostery Investments LP ($523K), JPMorgan Chase & Co. ($314K), and Heights Capital Management Inc. ($189K).Learn more on PHGE's institutional investors. What percentage of BiomX stock is owned by institutional investors? 40.57% of BiomX stock is owned by institutional investors. Learn more on PHGE's institutional investor holdings. Which institutional investors have been buying BiomX stock? The following institutional investors have purchased BiomX stock in the last 24 months: Ikarian Capital LLC ($11.71M), Alyeska Investment Group L.P. ($1.59M), Allostery Investments LP ($940.63K), Nantahala Capital Management LLC ($762.71K), AIGH Capital Management LLC ($701.54K), JPMorgan Chase & Co. ($429.99K), and ADAR1 Capital Management LLC ($299.60K). How much institutional buying is happening at BiomX? Institutional investors have bought a total of 16,535,151 shares in the last 24 months. This purchase volume represents approximately $52.47M in transactions. Which BiomX major shareholders have been selling company stock? The following institutional investors have sold BiomX stock in the last 24 months: Johnson & Johnson ($2.04M), 8VC GP I LLC ($977.57K), Barclays PLC ($450K), and Heights Capital Management Inc. ($330.54K). How much institutional selling is happening at BiomX? Institutional investors have sold a total of 3,794,641 shares in the last 24 months. This volume of shares sold represents approximately $4.45M in transactions. Related Companies Artiva Biotherapeutics Major Shareholders Adverum Biotechnologies Major Shareholders PepGen Major Shareholders Century Therapeutics Major Shareholders Precision BioSciences Major Shareholders Mural Oncology Major Shareholders Werewolf Therapeutics Major Shareholders Cue Biopharma Major Shareholders Forte Biosciences Major Shareholders ImmuCell Major Shareholders This page (NYSEMKT:PHGE) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiomX Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiomX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
